Jeffrey R. Luber became the CEO of Exact Sciences Corporation in March 2008, after holding various key roles in the company, including President and General Counsel. With degrees in business administration, law, and an MBA, Luber's educational background showcases a...
Jeffrey R. Luber became the CEO of Exact Sciences Corporation in March 2008, after holding various key roles in the company, including President and General Counsel. With degrees in business administration, law, and an MBA, Luber's educational background showcases a blend of business savvy and legal expertise. Under his leadership, Exact Sciences has focused on innovative diagnostic solutions, particularly targeting colorectal cancer with its flagship product, Cologuard, which has changed the way screening is done in the U.S. His tenure included notable highs, such as the bonuses tied to successfully navigating clinical trials and corporate goals. Luber's career before Exact Sciences was also significant. He worked in finance, administration, and legal capacities, giving him broad knowledge across different fields that benefit his role as CEO. With a focus on corporate performance metrics that directly affect the bottom line and stockholder interests, Luber represents a mix of operational experience and strategic financial insight. Over the years, he has proven to be a stabilizing force in a rapidly changing industry, making decisions that align with both patient needs and shareholder expectations.